Trial Profile
A Phase 2 Study of Pegylated Recombinant Human Growth Hormone Injection to Treat Children of Turner Syndrome
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Turner's syndrome
- Focus Therapeutic Use
- Sponsors GeneScience Pharmaceuticals
- 20 Jun 2017 New trial record